Green Cross becomes the fourth company succeeding in acquisition of tetravalent vaccine approval
On the 26th, Green Cross(CEO Eun-cheol Huh) announced acquisition of product approval of G C Flu Pre-filled Syringe Inj, a tetravalent influenza(flu) vaccine, from the Ministry of Food and Drug Safety.
Among other Asian pharmaceutical companies, Green Cross is the only company which acquired app...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
